Molecular Epidemiology Inc. was awarded a $102,417 firm fixed price delivery order against an unspecified government-wide acquisition contract to provide contract support services for the Food and Drug Administration's GenomeTrakr program. Under the terms of the award, Molecular Epidemiology Inc. will isolate 120 bacterial samples to support the FDA's efforts to track and analyze foodborne pathogens through whole genome sequencing and bioinformatics analysis over the approximately one-year period of performance ending in September 2024. No set-aside provisions were applied to this contract action placed by the Department of Health and Human Services for pathogen surveillance services in support of the FDA's GenomeTrakr initiative operated out of its Beltsville, Maryland facilities.
Generated 1/2/24, 12:49 PM